Back to today’s briefing

Story perspectives

Abbott Settles 2,000 Infant Formula NEC Lawsuits for $670 Million

8/21/2026

50 5 Full Breakdown

Summary

Story summary

Abbott Laboratories reached a $670 million settlement to resolve claims over its specialty infant formulas.
The settlement covers roughly 2,000 lawsuits alleging the formulas caused necrotizing enterocolitis in preterm infants.
One lawsuit, the Gill case, yielded a $495 million jury verdict upheld in May 2026.
Abbott did not admit liability, citing FDA and CDC positions that its formulas lack reliable scientific links to NEC.

1 of 1

Story summary

Abbott Laboratories reached a $670 million settlement to resolve claims over its specialty infant formulas.
The settlement covers roughly 2,000 lawsuits alleging the formulas caused necrotizing enterocolitis in preterm infants.
One lawsuit, the Gill case, yielded a $495 million jury verdict upheld in May 2026.
Abbott did not admit liability, citing FDA and CDC positions that its formulas lack reliable scientific links to NEC.